Is an ADS (per the article) the same as a regular share we would buy on the open market? Looks like around 25M shares outstanding for Mazor and Medtronic will end up owning under 5M or under 20% of the company.
To translate to Titan numbers, 20% is 110M shares, at .39/share is $42.9M. At maybe $.50/share, $55M. So worst case we end up with more than ample funding to get to finish line and start building/selling units! That's with a deal similarly structured to Mazor's deal.
News 
Market Data 
Discover 
